Process for making chloro-substituted nucleoside phosphoramidate compounds

US10214554B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10214554-B2
Application numberUS-201715427674-A
CountryUS
Kind codeB2
Filing dateFeb 8, 2017
Priority dateFeb 8, 2016
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).

First claim

Opening claim text (preview).

What is claimed is: 1. A process for making a compound of formula (i): wherein said process comprises the steps: (A) contacting a compound of Formula (B): with pivaloyl chloride, in the presence of a base in an optional organic solvent A, for a time and at a temperature sufficient to provide a mixture of a compound of Formula (C) and a compound of formula (D): wherein P is pivaloyl and optional organic solvent A is selected from acetonitrile, toluene, dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate, isopropyl acetate, N,N-dimethylformamide, pyridine, N,N-dimethylacetamide and N-methylpyrrolidone, and mixtures thereof; (B) contacting the mixture of the compound of formula (C) and the compound of formula (D) with an oxidizing agent in an organic solvent B, in the presence of an optional pH modifier, for a time and at a temperature sufficient to provide a compound of Formula (E): wherein P is pivaloyl and organic solvent B is selected from acetone, toluene, benzene, xylenes, cumene, cyclohexane, heptane, methylcyclohexane, dichloroethane, chlorobenzene, THF, anisole, ethyl acetate, isopropyl acetate, CPME, dichloromethane and mixtures thereof; (C) contacting the compound of Formula (E) with a compound of formula CH 3 MgX in the presence of a salt of formula R 50 Cl 2 or (CH 3 ) 2 AlX in an organic solvent C, for a time and at a temperature sufficient to provide a compound of Formula (F): wherein P is pivaloyl; R 50 is Mn or Zn; X is Br, Cl or I; and organic solvent C is selected from THF, 2-methyl THF, diethyl ether, dibutylether, cyclopentyl methyl ether, toluene, dimethoxyethane, anisole, xylenes and mixtures thereof; (D) contacting the compound of Formula (F) with a dehydrating agent, in the presence or absence of catalytic TMSCl or catalytic HCl or elemental sulfur, in an organic solvent D for a time and at a temperature sufficient to form a compound of formula (G): wherein P is a pivaloyl group and organic solvent D is selected from toluene, benzene, xylenes, cumene, cyclohexane, heptane, methylcyclohexane, dichloroethane, chlorobenzene, THF, anisole, ethyl acetate, isopropyl acetate, CPME and mixtures thereof; (E) contacting the compound of formula (G) with a base in an organic solvent E for a time and at a temperature sufficient to provide a compound of Formula (A): wherein organic solvent E is selected from organic alcohol solvents, toluene, benzene, xylenes, cumene, cyclohexane, heptane, methylcyclohexane, dichloroethane, chlorobenzene, DME, THF, anisole, ethyl acetate, isopropyl acetate, CPME, and mixtures thereof; and (F) contacting the compound of formula (A) with HCl or a compound of formula R (4-n) SiCl n in an organic solvent E for a time and at a temperature sufficient to provide a compound of Formula (i), wherein R is C 1 -C 6 alkyl or phenyl, and n is 1, 2 or 3. 2. The process of claim 1 , wherein step (B) is replaced by the following steps (B′) and (B″): (B′) contacting the mixture of the compound of formula (C) and the compound of formula (D) with BF 3 .OEt in an organic solvent B for at least one hour; and (B″) contacting the solution resulting from step B′ with and oxidizing agent for a time and at a temperature sufficient to provide a compound of Formula (E): wherein P is pivaloyl and organic solvent B is selected from acetone, toluene, benzene, xylenes, cumene, cyclohexane, heptane, methylcyclohexane, dichloroethane, chlorobenzene, THF, ethyl acetate, isopropyl acetate, CPME, dichloromethane and mixtures thereof. 3. The process according to claim 1 , wherein for step (A): the base is pyridine; and the organic solvent A is pyridine; and wherein for step (B): the oxidizing agent is (a) sodium hypochlorite/TEMPO in the presence of catalytic n-Bu 4 NBr or (b) sodium hypochlorite/TEMPO in the presence of catalytic n-Bu 4 NBr; and the organic solvent B is toluene; and wherein for step (C): the compound of formula TMSCH 2 MgX is TMSCH 2 MgCl; and the organic solvent C is toluene; and wherein for step (D): the fluoride ion source is a tetraalkyl ammonium fluoride or an alkali metal fluoride; the base is an alkali metal carbonate or DBU; and the organic alcohol is methanol; and wherein for step (E): the reducing agent is phenylsilane, tetramethyldisiloxane, diphenylsilane, triethylsilane or poly(methylhydrosiloxane); and the solvent E is water, DME, an organic alcohol, tetramethyldisiloxane or a mixture thereof. 4. The process according to claim 1 , wherein for step (A): the base is pyridine; and the organic solvent A is pyridine; and wherein for step (B): the oxidizing agent is (a) sodium hypochlorite/TEMPO in the presence of catalytic n-Bu 4 NBr or (b) sodium hypochlorite/TEMPO in the presence of catalytic n-Bu 4 NBr; and the organic solvent B is toluene; and wherein for step (C): the compound of formula TMSCH 2 MgX is TMSCH 2 MgCl; and the organic solvent C is toluene; and wherein for step (D): the fluoride ion source is a tetraalkyl ammonium fluoride or an alkali metal fluoride; the base is an alkali metal carbonate or DBU; and the organic alcohol is methanol; and wherein for step (E): the reducing agent is phenylsilane, tetramethyldisiloxane, diphenylsilane, triethylsilane or poly(methylhydrosiloxane); and the solvent E is water, DME, an organic alcohol, tetramethyldisiloxane or a mixture thereof.

Assignees

Inventors

Classifications

  • the hetero ring containing nitrogen as ring hetero atoms · CPC title

  • Phosphorylation · CPC title

  • Processes for the preparation of sugar derivatives · CPC title

  • C07H19/10Primary

    with the saccharide radical esterified by phosphoric or polyphosphoric acids · CPC title

  • Pyrimidine radicals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10214554B2 cover?
The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).
Who is the assignee on this patent?
Merck Sharp & Dohme
What technology area does this patent fall under?
Primary CPC classification C07H19/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).